Botulinum toxin A in the overactive bladder: current status and future directions.
Dmochowski
Roger
R
Department of Urology, Vanderbilt University, Nashville, TN 37232, USA. roger.dmochowski@vanderbilt.edu
Sand
Peter K
PK
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005544:Forecasting; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A